Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
100
datasets available to search
ShareScore release 0.9.0
Dataset results
100 results for “NMIBC”
A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT
ClinicalTrials.gov study NCT07313891. IPD Sharing: NO. Countries: 0. Publications: 2.
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT06929286. IPD Sharing: YES. Countries: 1. Publications: 0.
Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT03167151. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC
ClinicalTrials.gov study NCT04897763. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
ClinicalTrials.gov study NCT06443944. IPD Sharing: Not stated. Countries: 1. Publications: 2.
In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?
ClinicalTrials.gov study NCT03174912. IPD Sharing: UNDECIDED. Countries: 0. Publications: 2.
Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT01469221. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients
ClinicalTrials.gov study NCT07231809. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)
ClinicalTrials.gov study NCT04149574. IPD Sharing: Not stated. Countries: 16. Publications: 0.
Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT05136898. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 3 Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy
ClinicalTrials.gov study NCT07342517. IPD Sharing: NO. Countries: 0. Publications: 1.
Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC
ClinicalTrials.gov study NCT03719300. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT05704244. IPD Sharing: NO. Countries: 1. Publications: 0.
PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT05259397. IPD Sharing: NO. Countries: 2. Publications: 0.
Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT06126796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC
ClinicalTrials.gov study NCT06186414. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate Eciskafusp Alfa in Combination With Bacillus Calmette-guerin (BCG) in Participants With BCG-unresponsive High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT06816017. IPD Sharing: YES. Countries: 6. Publications: 0.
Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients
ClinicalTrials.gov study NCT02891460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT06350838. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT01475266. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.